Hofseth BioCare ASA reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was NOK 50.77 million compared to NOK 25.28 million a year ago. Revenue was NOK 76.43 million compared to NOK 25.83 million a year ago. Net income was NOK 5.76 million compared to net loss of NOK 28.38 million a year ago. Basic earnings per share from continuing operations was NOK 0.01 compared to basic loss per share from continuing operations of NOK 0.08 a year ago. Diluted earnings per share from continuing operations was NOK 0.01 compared to diluted loss per share from continuing operations of NOK 0.08 a year ago.
For the six months, sales was NOK 95.3 million compared to NOK 55.49 million a year ago. Revenue was NOK 121.2 million compared to NOK 56.62 million a year ago. Net loss was NOK 32.07 million compared to NOK 64.05 million a year ago. Basic loss per share from continuing operations was NOK 0.08 compared to NOK 0.18 a year ago. Diluted loss per share from continuing operations was NOK 0.08 compared to NOK 0.18 a year ago.